Robert W Duggan bought $778K of Pulse Biosciences (PLES)

Executed Dec 12 2024, disclosed Dec 17 2024, 5 days later, against a two-business-day limit.

Value, as filed

$778K

45,404 sh × $17.13

Executed

Dec 12 2024

the trade date, as filed

Disclosed

Dec 17 2024

5 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

RD Robert W Duggan Director profile →

Robert W Duggan (Director) filed 5 Form 4 reports in the trailing twelve months (5 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in PLSE. Across 4 priced purchase filings, the average 21-session return was +10.9% from execution and +11.5% from disclosure (delay-adjusted; derived). The largest single filing was $50.0M of SMMT (3,810,000 sh × $13.12, as filed), executed Jun 12.

The name

PLES PLES PLES · 1 filing in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→